BIVI - CIK 0001580149
The table below shows BIOVIE INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$3.02M | -$3.58M | -$12.18M | -$9.22M | -$2.53M | -$1.08M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | - | - | $14.53M | - | - | - |
| Dividends paid | - | - | - | - | - | - |
BIOVIE INC. reported operating cash flow of -$19.03M for fiscal year 2025. That is up 31.9% from -$27.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$153.63K (FY 2016) to -$19.03M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $10.46M | -$240.94K | -$594.16K | $11.81M | $18.51M | $14.24M |